Sunil H Abhyankar MD

Professor, Internal Medicine, Division of Hematological Malignancy and Cellular therapy, University Kansas School of Medicine

Join to View Full Profile

2330 Shawnee Mission PkwyStop 5003Westwood, KS 66205
Phone+1 913-588-6030
Fax+1 913-588-4085

Education & Training

SUNY Downstate Health Sciences UniversityFellowship, Pediatric Hematology/Oncology, 1987 - 1989
Seth G.S. Medical CollegeClass of 1981

Certifications & Licensure

KS State Medical License 2002 - 2026
MO State Medical License 2000 - 2026
SC State Medical License 1994 - 2021
KY State Medical License 1992 - 2001
NY State Medical License 1999 - 2001
WI State Medical License 1989 - 1991
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine Start of enrollment: 2010 Jan 01
Completed
Early Phase 1
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma Start of enrollment: 2010 Sep 01
Completed
Early Phase 1
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy. Start of enrollment: 2010 Aug 01
Completed
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease Start of enrollment: 2010 Jun 01
Completed
Early Phase 1
Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901) Start of enrollment: 2011 Jun 01
Terminated
Phase 3
Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Completed
Phase 3
Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE) Start of enrollment: 2014 Aug 29
Terminated
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
Completed
Phase 2
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
Recruiting
Phase 3
Roles: Contact
DALY II USA/ MB-CART2019.1 for DLBCL Start of enrollment: 2021 May 25
RECRUITING
PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

2 citations
Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trials.
Meizhang Li, Rupal Soder, Sunil Abhyankar, Trisha Home, Harsh Pathak
Cytotherapy. 2025-10-01
Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell tra...
Moazzam Shahzad, Muhammad Kashif Amin, Maggie Nelson, Abhinav Vyas, Joe S Al-Ramahi
Hematology, Transfusion and Cell Therapy. 2025-08-09
Advances in stem cell and cellular therapeutics from the 9th Midwest Conference on Cell Therapy and Regenerative Medicine.
Ramesh Balusu, Rupal Soder, Nathaniel Dudley, Joseph P McGuirk, Sunil Abhyankar
Molecular Therapy. 2025-08-06

Journal Articles

A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...
Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica

Press Mentions

Al-Ola a Abdallah: What if We Hit Cancer Cells from Multiple Angles?August 9th, 2025
“Triple Threat” CAR T-cell Therapy Clinical Trial Debuts at KU Cancer CenterAugust 5th, 2025
Cancer Center Is a Contributor to 49 Research Studies at the 62nd American Society of Hematology Annual MeetingDecember 4th, 2020
Join now to see all

Sunil H Abhyankar MD

Dr. Abhyankar is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.